Sun Pharmaceutical Industries Ltd share price logo

Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA

BSE: 524715

Large Cap

Healthcare Sector

Pharma Sector

₹1779.70

-21.30

(-1.18%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

What are INDmoney investors doing with Sun Pharmaceutical Industries shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-12%

Searches for Sun Pharmaceutical Industries on INDmoney have decreased by 12% over the last 30 days.

Investment activity on INDmoney

-22.00%

Investment activity in Sun Pharmaceutical Industries among INDmoney users has decreased by 22.00% over the last 30 days.

Among the most traded stocks

118th

Sun Pharmaceutical Industries was the 118th most traded stock on INDmoney over the last 7 days.

Among the most watchlisted stocks

97th

Sun Pharmaceutical Industries was the 97th most watchlisted stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

43 days

INDmoney investors hold Sun Pharmaceutical Industries shares for an average of 43 days.

Key Events for Sun Pharmaceutical Industries

Last Dividend Declared

₹5.00 per share, declared on 22/05/2026

View Dividend History

Sun Pharmaceutical Industries Stock Performance

as on October 5, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,776.70
    ₹1,802.90
    downward going graph

    0.17%

    Downside

    1.30%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹1,583.70
    ₹2,046.90
    downward going graph

    11.01%

    Downside

    15.01%

    Upside

    downward going graph

Sun Pharmaceutical Industries share price movements today

Previous Close
₹1,801.00
Open
₹1,785.00
Volume
12.91L
Upper Circuit
₹1,831.80
Lower Circuit
₹1,725.20
Day's Low - High
₹1,776.70 - ₹1,802.90
52 Week Low - High
₹1,583.70 - ₹2,046.90

Sun Pharmaceutical Industries Historical Returns

1 Month Return
-4.96 %
3 Month Return
-5.84 %
1 Year Return
+ 8.84 %
3 Year Return
+ 60.93 %
5 Year Return
+ 119.5 %

Sun Pharmaceutical Industries Fundamentals

as on October 5, 2026 at 4:01 pm IST

Market Cap

₹4,32,120.23 Cr

Return on Equity (ROE)

12.73

PE Ratio (TTM)

35.73

Return on capital employed (ROCE)

14.47

Industry PE ratio

51.84

Beta (LTM)

0.46

P/B Ratio

18.85

Dividend Yield

0.91

PEG Ratio

5.03

Quarterly Earnings Growth YOY

26.41

EPS (TTM)

48.2

Book Value

348.31

Sun Pharmaceutical Industries Stock Valuation

as on October 5, 2026 at 4:01 pm IST

Sun Pharmaceutical Industries in the last 5 years

  • Overview

  • Trends

Lowest (19.47x)

March 23, 2020

Today (35.73x)

October 1, 2026

Industry (51.84x)

October 1, 2026

Highest (184.63x)

August 28, 2020

LowHigh

Today’s Price to Earnings Ratio: 35.73x

Sun Pharmaceutical Industries Technical Analysis

Track how Sun Pharmaceutical Industries technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish12
Bullish1
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
-0.52
Bullish
CCI (20)
-24.25
Neutral
RSI (14)
43.75
Neutral
Momentum (10)
-2.4
Bearish
ADI (14)
55.12
Bearish
Ultimate Oscillator (7,14,28)
7.73
Bearish

Moving Averages

Name

Value

Action

SMA (20)
1777.93
Bearish
EMA (20)
1778.06
Bearish
VWMA (20)
1777.83
Bearish
SMA (50)
1779.68
Bearish
EMA (50)
1779.23
Bearish
SMA (200)
1783.16
Bearish
EMA (200)
1783.28
Bearish
KAMA (200)
1780.89
Bearish
DEMA (200)
1778.34
Bearish

Sun Pharmaceutical Industries Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sun Pharmaceutical Industries with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY4,32,120.2323.9%0.5411,56458,462
BUY2,45,531.8915.45%0.522,56810,560
BUY1,81,332.7740.94%0.872,13819,274
HOLD60,412.760.48%0.6836816,927
BUY47,430.72-5.74%0.521,0276,430

Market expectation of Sun Pharmaceutical Industries Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

87.10%

Buy

3.23%

Hold

9.68%

Sell

Sun Pharmaceutical Industries Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
12,156.86
11,813.33
12,524.51
13,264.22
13,436.94
12,815.58
13,786.07
14,405.22
15,469.07
14,559.75
15,183.55
Other Income
250.2
605.94
532.55
354
465.62
612.87
464.46
469.92
578.84
458.5
723.62
Total Income
12,630.9
12,588.84
13,185.3
13,645.39
14,141.08
13,571.71
14,315.86
14,948.23
16,099.38
15,070.29
16,023.5
Expenses
8,973.68
9,049.39
9,045.13
9,352.43
9,982.61
9,604.43
10,367.74
9,951.26
11,061.53
10,657.59
11,086.3
Operating Profit
3,183.18
2,763.94
3,479.38
3,911.79
3,454.33
3,211.15
3,418.33
4,453.96
4,407.54
3,902.16
4,097.25
Operating Profit Margin %
26.18%
23.4%
27.78%
29.49%
25.71%
25.06%
24.8%
30.92%
28.49%
26.8%
26.98%
Profit Before Interest, Tax and Depreciation
3,657.22
3,539.45
4,140.17
4,292.96
4,158.47
3,967.28
3,948.12
4,996.97
5,037.85
4,412.7
4,937.2
Interest
34.73
73.57
61.54
69.17
51.51
49.14
74.8
99.86
78.36
85.89
99.67
Depreciation
622.14
650.36
655.13
625.91
630.56
663.79
700.55
729.5
732.33
775.47
738.72
Profit Before Tax
3,000.35
2,815.52
3,423.5
3,597.88
3,476.4
3,254.35
3,172.77
4,167.61
4,227.16
3,551.34
4,098.81
Tax Paid
432.32
148.93
552.25
567.21
558.86
1,093.71
870.15
1,030.52
826.07
827.62
1,188.01
Profit After Tax
2,568.03
2,666.59
2,871.25
3,030.67
2,917.54
2,160.64
2,302.62
3,137.09
3,401.09
2,723.72
2,910.8
Total Net profit including share of profit / Loss from associate company
2,560.54
2,658.74
2,860.51
3,037.33
2,912.98
2,153.93
2,292.87
3,124.95
3,381.17
2,709.66
2,901.23
EPS
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
11.3
12.1
Actual EPS
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
11.3
12.1
Adjusted EPS
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
11.3
12.1
Diluted EPS
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
11.3
12.1

Sun Pharmaceutical Industries Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
26,065.94
28,686.28
32,325.17
33,233.08
38,426.42
43,278.87
47,758.45
52,041.25
58,220.11
Other Income
838.76
1,025.49
635.98
835.52
921.51
634.52
1,354.19
1,965.04
1,971.72
Total Income
27,328.22
30,091.4
33,473.48
34,333.66
39,576
44,520.2
49,851.04
54,543.48
60,433.76
Expenses
21,831.83
23,972.7
26,108.38
29,312.91
32,823.59
32,410.34
35,968.04
37,984.6
42,038.12
Operating Profit
4,234.11
4,713.58
6,216.79
3,920.17
5,602.83
10,868.53
11,790.41
14,056.65
16,181.99
Operating Profit Margin %
16.24%
16.43%
19.23%
11.8%
14.58%
25.11%
24.69%
27.01%
27.79%
Profit Before Interest, Tax and Depreciation
5,496.39
6,118.7
7,365.1
5,020.75
6,752.41
12,109.86
13,883
16,558.88
18,395.64
Interest
517.57
555.25
302.73
141.43
127.35
172
238.47
231.36
338.91
Depreciation
1,499.84
1,753.25
2,052.78
2,079.95
2,143.74
2,529.43
2,556.64
2,575.39
2,937.85
Profit Before Tax
3,478.98
3,810.2
5,009.59
2,799.37
4,481.32
9,408.43
11,087.89
13,752.13
15,118.88
Tax Paid
911.04
600.88
822.8
514.69
1,075.5
847.59
1,439.45
2,772.03
3,554.36
Profit After Tax
2,567.94
3,209.32
4,186.79
2,284.68
3,405.82
8,560.84
9,648.44
10,980.1
11,564.52
Total Net profit including share of profit / Loss from associate company
2,542.5
3,207.86
4,171.96
2,272.35
3,389.28
8,512.94
9,610.03
10,964.75
11,508.65
EPS
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
47.8
Actual EPS
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
47.8
Adjusted EPS
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
47.8
Diluted EPS
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
47.8

Sun Pharmaceutical Industries Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
6,685.86
7,082.21
3,907.15
2,196.45
6,554.77
6,170.37
8,984.54
4,959.33
12,134.98
14,072.09
12,419.18
Cash Flow from Investing Activities
-3,949.13
-4,186.15
-3,103.8
-310.08
-2,225.32
406.53
-5,555.86
-7,219.92
-762.9
-5,183.15
-10,404.89
Cash Flow from Financing Activities
-1,888.53
-2,285.39
-1,539.26
-2,730.52
-5,715.14
-5,980.48
-5,193.46
2,376.07
-6,710.16
-7,905.82
-2,512.55
Net Cash Flow
848.2
610.67
-735.91
-844.15
-1,385.69
596.42
-1,764.78
115.48
4,661.92
983.12
-498.26

Sun Pharmaceutical Industries Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
DII
17.97%
18.83%
19.28%
18.61%
18.55%
18.7%
19.5%
20.23%
20.82%
21.11%
22.18%
FII
0%
17.72%
17.23%
18.02%
18.05%
17.96%
17.26%
16.55%
16.12%
15.93%
14.53%
Public
8.92%
8.97%
9.01%
8.89%
8.92%
8.87%
8.77%
8.73%
8.58%
8.48%
8.81%
Total Outstanding Shares
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
Total Shareholders
6,12,626
6,31,392
6,73,217
6,57,317
6,89,623
7,04,983
7,23,770
7,43,877
7,10,900
6,90,957
7,10,246

Mutual Funds Buying / Exiting Sun Pharmaceutical Industries

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Sun Pharmaceutical Industries

Sorted by largest increase in holding, month-over-month.

No buying activity data available right now

No buying activity data available right now

Mutual Funds Exiting Sun Pharmaceutical Industries

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

Nippon India Large Cap Fund - Direct Plan - Growth Plan

Nippon India Large Cap Fund - Direct Plan - Growth Plan

₹1,095.29 Cr

₹76.89 Cr (-6.56%)

2.26%

Sun Pharmaceutical Industries Corporate Actions

View detailed summary of the earnings and dividend history of Sun Pharmaceutical Industries.

  • Sun Pharmaceutical Industries Ltd Earnings Results

    Sun Pharmaceutical Industries Ltd’s net profit jumped 27.04% since last year same period to ₹2,894.79Cr in the Q1 2026-2027. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated 6.66% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Sun Pharmaceutical Industries Ltd Dividends May,2026

    In the quarter ending March 2026, Sun Pharmaceutical Industries Ltd has declared dividend of ₹5.00 per share on 22 May 2026 - translating a dividend yield of 0.89%.

    Read More about Dividends

Indices Featuring Sun Pharmaceutical Industries Stock

Check stock indices that include Sun Pharmaceutical Industries.

Nifty100 Low Volatility 30

₹18,665.60

+77.65 (▲0.42%)

S&P BSE SENSEX 50

₹23,695.24

+145.57 (▲0.62%)

Nifty LargeMidcap 250

₹15,687.65

+82.95 (▲0.53%)

S&P BSE 100 ESG

₹383.63

+2.29 (▲0.60%)

Nifty Healthcare

₹15,934.65

-160.90 (▲1.00%)

BSE 200

₹10,619.02

+57.57 (▲0.55%)

S&P BSE 250 LargeMidCap

₹10,133.68

+51.23 (▲0.51%)

BSE MFG

₹1,012.53

+7.63 (▲0.76%)

S&P BSE Low Volatility

₹1,627.68

+3.18 (▲0.20%)

BSE Healthcare

₹49,334.68

-565.26 (▲1.13%)

NIFTY 100

₹23,645.30

+128.80 (▲0.55%)

Nifty 200

₹13,121.05

+74.60 (▲0.57%)

SENSEX

₹72,382.47

+472.77 (▲0.66%)

NIFTY 50

₹22,555.75

+133.80 (▲0.60%)

BSE 500

₹34,387.91

+166.50 (▲0.49%)

NIFTY PHARMA

₹26,117.10

-194.45 (▲0.74%)

S&P BSE 100 LargeCap TMC

₹8,537.64

+46.59 (▲0.55%)

S&P BSE Dividend Stability

₹970.03

+4.79 (▲0.50%)

Nifty100 Eq Weig

₹32,604.45

+113.70 (▲0.35%)

Nifty 500

₹21,971.60

+113.85 (▲0.52%)

BSE 100

₹24,179.80

+150.16 (▲0.62%)

Insights on Sun Pharmaceutical Industries Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, SUNPHARMA stock has moved up by 8.8%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 2.71K Cr → 2.89K Cr (in ₹), with an average increase of 6.2% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 11.96% to 12.84% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 8.48% to 8.81% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 15.07K Cr → 16.02K Cr (in ₹), with an average increase of 6.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 58.7% return, outperforming this stock by 49.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.6% return, outperforming this stock by 96.7%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 54.48% of holdings in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 15.93% to 14.53% in Jun 2026 quarter

Sun Pharmaceutical Industries Stock Futures & Options Contracts

View the latest movement in Sun Pharmaceutical Industries Futures & Options, including strike prices, expiry dates, and percentage changes.

Sun Pharmaceutical Industries Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
SUNPHARMA 27 Oct ₹1800 Call
October 27, 2026
₹1800
₹24.6
-16.95
-40.79%
SUNPHARMA 27 Oct ₹1900 Call
October 27, 2026
₹1900
₹4.15
-3.9
-48.45%
SUNPHARMA 27 Oct ₹1860 Call
October 27, 2026
₹1860
₹8.3
-7.6
-47.8%
SUNPHARMA 27 Oct ₹1820 Call
October 27, 2026
₹1820
₹17.25
-14.35
-45.41%

Sun Pharmaceutical Industries Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
SUNPHARMA 27 Oct Fut
October 27, 2026
-
₹1778.5
-34.45
-1.9%
SUNPHARMA 23 Nov Fut
November 23, 2026
-
₹1788.5
-33.15
-1.82%
SUNPHARMA 29 Dec Fut
December 29, 2026
-
₹1796
-36.65
-2%

About Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd., incorporated in 1983, is a global specialty generic pharmaceuticals company with a presence in over 150 countries. The company is headquartered in Mumbai, India, and has operations in three primary lines of business: branded formulations, specialty generics, and active pharmaceutical ingredients (API).

Sun Pharma's branded formulations include products for cardiovascular, central nervous system, gastroenterology, ophthalmology, and dermatology. Sun Pharma's specialty generics include injectables, inhalants, and complex products. Sun Pharma's API portfolio includes products for a range of therapeutic areas, including cardiovascular, central nervous system, gastroenterology, and dermatology.

Sun Pharma's top products include Modalert, a generic version of Modafinil for treating sleep disorders; Glocip, a generic version of Glipizide for treating diabetes; and Doxicip, a generic version of Doxycycline for treating bacterial infections. Sun Pharma's popular brands include Revital, a multivitamin supplement; Tazret, a topical retinoid for treating psoriasis; and Olmecip, a generic version of Olmesartan for treating hypertension.

Revenue: ₹15,183.55Cr as on June 2026 (Q1 FY27)
Net Profit: ₹2,910.80Cr as on June 2026 (Q1 FY27)
Listing date: 08 Feb, 1995
Revital Share Price
Volini Share Price
Abzorb Share Price
Pepfiz Share Price
OrganisationSun Pharmaceutical Industries Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Sun Pharmaceutical Industries share price today?

Sun Pharmaceutical Industries share price today stands at ₹1779.7 as on at the close of the market. Sun Pharmaceutical Industries share today touched a day high of ₹1802.9 and a low of ₹1776.7.

What is the 52 week high and 52 week low range for Sun Pharmaceutical Industries share?

Sun Pharmaceutical Industries touched a 52 week high of ₹2046.9 and a 52 week low of ₹1583.7. Sun Pharmaceutical Industries share price today i.e. is closed at ₹1779.7, which is -13.05% down from its 52 week high and 12.38% up from its 52 week low.

What is Sun Pharmaceutical Industries's market capitalisation today?

Sun Pharmaceutical Industries market capitalisation is ₹4,32,120.23 Cr as on .

How to buy Sun Pharmaceutical Industries shares?

To buy Sun Pharmaceutical Industries shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SUNPHARMA or Sun Pharmaceutical Industries Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Sun Pharmaceutical Industries shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sun Pharmaceutical Industries trading volume today?

Sun Pharmaceutical Industries trading volume is 12.91L as on . This means that 12.91L shares of Sun Pharmaceutical Industries were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Sun Pharmaceutical Industries shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Sun Pharmaceutical Industries have both decreased over the past 30 days, and the average INDmoney investor holds the stock for 43 days. This reflects platform activity only and is not investment advice.